Asthma cough
Pro Research Analysisby 
Searched over 200M research papers for "asthma cough"
Consensus Meter
Understanding Asthma-Related Cough: Causes, Diagnosis, and Treatment
Introduction to Asthma-Related Cough
Asthma is a prevalent respiratory condition characterized by airway hyperresponsiveness and inflammation, often leading to symptoms such as wheezing, dyspnea, and cough. Among these, chronic cough can be a particularly troublesome symptom, sometimes presenting as the sole or predominant manifestation of asthma, known as cough-variant asthma (CVA) . This article explores the mechanisms, diagnosis, and treatment options for asthma-related cough, drawing on recent research findings.
Mechanisms of Cough in Asthma
Pathophysiology and Triggers
The mechanisms underlying cough in asthma are complex and multifactorial. Asthma-related cough is often associated with airway hyperresponsiveness and inflammation, which can be triggered by various factors such as allergens, cold air, exercise, and occupational exposures . Recent studies suggest that acute bronchoconstriction can increase the activation of capsaicin-responsive airway nerves, thereby enhancing the cough reflex. Additionally, neuronal dysfunction and heightened airway sensitivity are thought to play significant roles in persistent coughing among asthma patients.
Cough-Variant Asthma (CVA)
CVA is a subtype of asthma where cough is the predominant or sole symptom, without the typical wheezing or dyspnea. Diagnosing CVA can be challenging as physical examination and spirometry findings may appear normal. Methacholine inhalation challenge testing is often used to demonstrate bronchial hyperresponsiveness, confirming the diagnosis when the cough resolves with antiasthmatic therapy .
Diagnosis of Asthma-Related Cough
Diagnostic Tools and Challenges
Diagnosing asthma-related cough involves a combination of clinical history, physical examination, and pulmonary function tests. Spirometry is a key diagnostic tool, measuring parameters such as FEV1 and FVC to assess airflow obstruction and its reversibility with bronchodilators. However, normal spirometry does not rule out asthma, and further tests like methacholine challenge or peak flow monitoring may be necessary.
Role of Biomarkers
Non-invasive biomarkers such as induced sputum and fractional exhaled nitric oxide (FeNO) have been explored for their potential in evaluating airway inflammation in asthma-related cough. However, evidence supporting their specific benefit in managing chronic cough due to asthma remains weak.
Treatment Options for Asthma-Related Cough
Standard Antiasthmatic Therapy
The primary treatment for asthma-related cough involves standard antiasthmatic medications. Inhaled corticosteroids are the cornerstone of therapy, effectively reducing airway inflammation and hyperresponsiveness. For patients who do not respond adequately, leukotriene receptor antagonists and short courses of oral corticosteroids may be added .
Addressing Persistent Cough
Despite standard treatments, some patients continue to experience persistent coughing. This may be due to underlying neuronal dysfunction or other factors not fully addressed by conventional therapies. Identifying and treating these patients as a distinct neuro-phenotype could help reduce the disease burden and improve quality of life .
Clinical Implications and Future Research
Impact on Quality of Life
Chronic cough in asthma is associated with increased airway inflammation, more comorbidities, and worse clinical outcomes. Patients with persistent cough often report greater work productivity loss, daily activity impairment, and increased healthcare utilization. Therefore, addressing chronic cough in asthma is crucial for improving overall disease management and patient well-being.
Need for Precision Medicine
Current asthma management guidelines may not adequately address the heterogeneity of asthma symptoms, including cough. The concept of treatable traits, where each symptom is managed as an individual entity, is fundamental to precision medicine. This approach could help tailor treatments more effectively to the specific needs of patients with asthma-related cough.
Conclusion
Asthma-related cough, particularly in the form of cough-variant asthma, presents unique diagnostic and therapeutic challenges. While standard antiasthmatic therapies remain the mainstay of treatment, persistent cough in some patients highlights the need for a more nuanced approach. Future research should focus on understanding the underlying mechanisms of cough in asthma and developing targeted treatments to improve patient outcomes.
Sources and full results
Most relevant research papers on this topic